CD8A and myeloid leukemia: The association between reduced mitochondrial activity and cytotoxic effects of ArtinM has been reported when stimulating a few cell types, such as murine CD4+ and CD8+ T cells [23], NB4 human myeloid leukemia cells [27], and Jurkat human leukemic T cells [23].